Almirall at bottom of Ibex after weak 9-months results

IBEX

15/11/2021 09:12

** Shares in Almirall  ALM.MC  drop 7.5% after the company
reported a 9-month net loss of 39.4 million euros ($45.10
million)
    ** The Spanish pharmaceuticals company said it remained in
the red in the first nine months as a result of a the 103
million euro write-down of the book value of its anti-acne drug
 urn:newsml:reuters.com:*:nL8N2S60VU
    ** Sabadell brokerage said Almirall's Q3 results were
"weaker than expected at the operating level" 
    ** Jefferies notes the results were a "miss" to the broker's
and consensus expectations for a loss of 26 million euros and 30
million euros respectively
    ** It adds however that it remains confident mid-long term
in the dermatological portfolio
    ** Shares are at the bottom of Spanish blue chip index
 .IBEX  with price at its lowest since March

($1 = 0.8737 euros)

 (Reporting by Aida Pelaez-Fernandez in Gdansk)
 ((Aida.Pelaez-Fernandez@thomsonreuters.com))